Health-related quality of life over chemotherapy course among individuals with early-stage breast cancer: the association of social determinants of health and neighborhood socioeconomic disadvantage

• Published in: Supportive care in cancer 2024-04, Vol.32 (4), p.224-224, Article 224
• Main Authors: You, Kai-Lin, Sereika, Susan M., Bender, Catherine M., Hamilton, Jill B., Mazanec, Susan R., Brufsky, Adam, Rosenzweig, Margaret Quinn
• Format: Article
• Language: English
• Subjects: Breast cancer; Breast Neoplasms - drug therapy; Cancer therapies; Chemotherapy; Female; Humans; Longitudinal Studies; Medicine; Medicine & Public Health; Nursing; Nursing Research; Oncology; Pain Medicine; Quality of Life; Rehabilitation Medicine; Social Determinants of Health; Socioeconomic Disparities in Health; Well being; White people; Womens health
• ISSN: 0941-4355; 1433-7339
• DOI: 10.1007/s00520-024-08429-y

Purpose This study aimed to examine relationships between health-related quality of life (HRQOL), social determinants of health, and neighborhood socioeconomic disadvantage in individuals with early-stage breast cancer (ESBC) during chemotherapy. Methods This is a longitudinal study that recruited Black and White women with ESBC receiving chemotherapy. Participants completed questionnaires recording their sociodemographic information at baseline and the Functional Assessment of Cancer Therapy–General (FACT-G) to report their HRQOL before each chemotherapy cycle. Linear mixed modeling was employed to examine the associations between FACT-G scores, self-reported race, and area deprivation index (ADI) before and at the last chemotherapy cycle, with the duration of chemotherapy treatment as a covariate. Results A total of 84 Black and 146 White women with ESBC completed the surveys. Linear mixed modeling results suggested that women with ESBC who reported being Black experienced significantly worse physical well-being than those who reported being White throughout chemotherapy, with a 0.22-point lower average ( p  = 0.02). Both Black and White women with ESBC experienced decreased functional well-being over the chemotherapy, and Black women consistently reported lower scores than White women, with the change in functional well-being over time differing between racial groups ( p  = 0.03). Participants’ ADI national percentiles were not significantly associated with their HRQOL throughout chemotherapy. Conclusions These findings underscore possible racial differences in some dimensions of HRQOL during chemotherapy among women with ESBC. Future research should consider further assessing life stressors and past experiences of discrimination and racism that may contribute to these disparities and guide proactive interventions.